Table 1.
Participant numbers from the four data sets used in this study.
Study | ASD participants | TD participants | Inclusion criteria |
---|---|---|---|
IMAGE case–control | 92 | 82 | Complete panel of 15 FOCM/TS measurements |
MeCbl + LDFA trial | 33 | 0 | Complete pre- and post-treatment panel of 15 FOCM/TS measurements with VABS Composite |
BH4 trial | 8 | 0 | |
HDFA trial | 14 (+19 placebo) | 0 | |
Placebo∗ | 19 | 0 | |
∗All members of the placebo group analyzed in this study came from the HDFA trial.